RAC 3.79% $1.53 race oncology ltd

STRONG SELL/ 50% downside potential, page-19

  1. 11,249 Posts.
    lightbulb Created with Sketch. 29638
    ... and the Micromet buyout occurred based on a Phase 2 trial.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.